Re WHO’s emergency use listing procedure assesses the quality, safety and efficacy of #COVID19 vaccines and is a prerequisite for #COVAX vaccine supp…


Re WHO’s emergency use listing procedure assesses the quality, safety and efficacy of #COVID19 vaccines and is a prerequisite for #COVAX vaccine supply.
It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.

World Health Organization (WHO): 🆕 WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against #COVID19.
The vaccine is produced by the Serum Institute of India under licence from Novavax

https://bit.ly/3yzxxaj

Liked Liked 3 views